OFG
BMY icon

OmniStar Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

OmniStar Financial Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.37M Buy
58,507
+4,345
+8% +$249K 1.55% 16
2026
Q1 		$3.28M Buy
+54,162
New +$3.16M 1.7% 13
2025
Q3 		– Sell
-14,978
Closed -$693K – 116
2025
Q2 		$693K Buy
14,978
+1,826
+14% +$89.6K 0.52% 57
2025
Q1 		$802K Buy
+13,152
New +$767K 0.63% 52
2024
Q3 		– Sell
-13,316
Closed -$553K – 128
2024
Q2 		$553K Buy
13,316
+224
+2% +$10K 0.5% 84
2024
Q1 		$710K Sell
13,092
-3,000
-19% -$153K 0.65% 55
2023
Q4 		$826K Sell
16,092
-5,981
-27% -$314K 1.04% 30
2023
Q3 		$1.28M Buy
22,073
+2,437
+12% +$149K 1.52% 14
2023
Q2 		$1.26M Buy
19,636
+1,279
+7% +$85.8K 1.48% 17
2023
Q1 		$1.27M Buy
18,357
+1,417
+8% +$99.9K 1.61% 14
2022
Q4 		$1.22M Buy
16,940
+468
+3% +$35.3K 1.38% 22
2022
Q3 		$1.17M Sell
16,472
-2,703
-14% -$196K 1.4% 21
2022
Q2 		$1.48M Buy
19,175
+1,896
+11% +$144K 1.64% 14
2022
Q1 		$1.26M Sell
17,279
-3,863
-18% -$259K 1.25% 24
2021
Q4 		$1.32M Buy
21,142
+1,426
+7% +$83.7K 1.35% 24
2021
Q3 		$1.17M Buy
+19,716
New +$1.3M 1.38% 20
2021
Q2 		– Sell
-18,278
Closed -$1.19M – 114
2021
Q1 		$1.15M Sell
18,278
-12,482
-41% -$777K 1.47% 17
2020
Q4 		$1.91M Sell
30,760
-11,435
-27% -$703K 1.34% 24
2020
Q3 		$2.54M Buy
42,195
+510
+1% +$30.7K 1.92% 13
2020
Q2 		$2.45M Buy
41,685
+19,397
+87% +$1.16M 2.03% 10
2020
Q1 		$1.24M Buy
22,288
+8,123
+57% +$496K 1.22% 25
2019
Q4 		$909K Sell
14,165
-13,129
-48% -$752K 0.77% 51
2019
Q3 		$1.38M Sell
27,294
-483
-2% -$22.7K 1.21% 31
2019
Q2 		$1.26M Sell
27,777
-317
-1% -$14.8K 1.13% 36
2019
Q1 		$1.34M Buy
28,094
+6,393
+29% +$318K 1.18% 36
2018
Q4 		$1.13M Buy
21,701
+1,822
+9% +$97.9K 1.15% 37
2018
Q3 		$1.23M Buy
+19,879
New +$1.18M 0.94% 42

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

OmniStar Financial Group's BMY Position: Q2 2026 in Review

OmniStar Financial Group increased its Bristol-Myers Squibb (BMY) stake by 8% in Q2 2026, buying an estimated $249K and bringing the position to 58,507 shares worth $3.37M. The position accounts for 1.55% of the portfolio, ranked #16.

OmniStar Financial Group first reported a position in BMY in Q3 2018 and has held it in 27 quarters since. 904 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • OmniStar Financial Group held 58,507 shares of Bristol-Myers Squibb worth $3.37M as of Q2 2026.
  • OmniStar Financial Group bought 4,345 Bristol-Myers Squibb shares in Q2 2026, an estimated $249K.
  • Bristol-Myers Squibb made up 1.55% of OmniStar Financial Group's portfolio in Q2 2026, its #16 holding.
  • OmniStar Financial Group first reported a position in Bristol-Myers Squibb in Q3 2018 and has held it in 27 quarters since.
  • 904 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on OmniStar Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.